KIORA PHARMACEUTICALS INC - COM NEW (KPRX)

CUSIP: 49721T309

Q4 2023 13F Holders as of 31 Dec 2023

Share change
+142,671
SEC-reported price per share
$0.52
Number of holders
15
Value change
+$74,823
Number of buys
5
Number of sells
5

Security key

49721T309

Report period

Q4 2023

Institutions

15

Top holders

10

Ownership snapshot

Top reported holders of KPRX - KIORA PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $3,006,550 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $3.01M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Disclosed position value Top 5
ARMISTICE CAPITAL, LLC $3.01M
Stephen From $259.3K
Sarah Romano $87.1K
Michael P. Manzo $58.9K
Brenda Mann $58K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
3/4/5
10%+ Owner
—
denominator unverified
$3,006,550
785,000 shares
— 30 Jul 2021
Stephen From
3/4/5
Executive Chairman, Director
—
denominator unverified
$259,264
67,693 shares
— 05 Jan 2022
Sarah Romano
3/4/5
Chief Financial Officer
—
mixed-class rows
$87,117
72,746 shares
mixed-class rows
— 10 Feb 2022
Michael P. Manzo
3/4/5
VP of Engineering
—
denominator unverified
$58,898
15,378 shares
— 03 Aug 2021
Brenda Mann
3/4/5
VP of Research & Development
—
denominator unverified
$57,971
15,136 shares
— 02 Nov 2021
CAPTRUST FINANCIAL ADVISORS
13F
Company
13F
—
denominator unverified
$45,416
80,000 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
15
Shares
302,724
Rows available
15
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
14
Q4 2023 holders
15
Holder diff
1
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .